Company: HROW
Filing Date: 2025-08-11
Form Type: 10-Q
Source: 0001641172-25-022980
Chunk: 24

Company: HARROW, INC.
Filing Date: 2025-08-11
Form: 10-Q
Item: Item 1
Chunk 24
---
31, 2024 were recognized as revenue during 2025.

NOTE
4. INVENTORIES

Inventories
are comprised of finished compounded formulations, over-the-counter and prescription retail pharmacy products, branded pharmaceutical
products, including those held at the Company’s 3PL partner, related laboratory supplies and active pharmaceutical ingredients.
The composition of inventories as of June 30, 2025 and December 31, 2024 was as follows:

 SCHEDULE
OF INVENTORIES

    June 30, 2025  
    December 31, 2024 
  
    Raw materials 
    $5,825,000  
    $5,362,000 
  
    Work in progress 
     793,000  
     858,000 
  
    Finished goods 
     4,934,000  
     4,482,000 
  
    Total inventories 
    $11,552,000  
    $10,702,000 

NOTE
5. PREPAID EXPENSES AND OTHER CURRENT ASSETS

Prepaid
expenses and other current assets at June 30, 2025 and December 31, 2024 consisted of the following:

 SCHEDULE
OF PREPAID EXPENSES AND OTHER CURRENT ASSETS

    June 30, 2025  
    December 31, 2024 
  
    Prepaid insurance 
    $224,000  
    $1,326,000 
  
    Prepaid computer software licenses and related expenses 
     709,000  
     765,000 
  
    Prefunded co-pay assistance 
     2,937,000  
     4,514,000 
  
    Other prepaid expenses 
     3,387,000  
     1,435,000 
  
    Receivable due from Melt 
     228,000  
     228,000 
  
    Annual Prepaid Prescription Drug User (“PDUFA”) fees 
     1,217,000  
     3,651,000 
  
    Deposits and other current assets 
     2,851,000  
     3,410,000 
  
    Total prepaid expenses and other current assets 
    $11,553,000  
    $15,329,000 

NOTE
6. PROPERTY, PLANT AND EQUIPMENT

Property,
plant and equipment at June 30,